Market News & Trends
pSivida Announces Evaluation Agreement for Protein/Antibody Delivery System
pSivida Corp. recently announced it has signed a funded technology evaluation agreement with a leading global biopharmaceutical company to evaluate pSivida's Tethadur protein/antibody delivery technology…
7/25/2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was led by new investor Aisling…
Agile Therapeutics Raises $40 Million
Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was led by new investor Aisling Capital, LLC, who joins existing…
Array BioPharma Reaches Multi-Million Dollar Milestone
Array BioPharma Inc. recently announced that an $8.5-million milestone was achieved in its collaboration with Amgen. Array entered into an agreement with Amgen in December…
BioTime Signs Agreements With Jade Therapeutics
BioTime, Inc. recently announced the signing of an exclusive sublicense agreement and a supply agreement with Jade Therapeutics, LLC, a developer of an ophthalmological therapeutic…
Infinity Pharmaceuticals Regains Worldwide Rights to Multiple Programs
Infinity Pharmaceuticals, Inc. recently announced it has restructured its strategic alliance with Mundipharma International Corporation Limited and Purdue Pharmaceutical Products L.P. by mutual agreement. With…
R-Tech Ueno to Collaborative With Tohoku University on New Delivery System
R-Tech Ueno recently announced it will conduct a collaborative study with Tohoku University, a national university corporation, to develop a drug delivery system for Isopropyl…
Thermo Fisher Scientific Launches New Extruder for Pharmaceutical Research
Thermo Fisher Scientific Inc., recently announced it launched the Thermo Scientific Pharma 11, a new version of its parallel co-rating twin-screw extruder designed specifically for…
FDA Approves Cornerstone Therapeutics' ANDA
Cornerstone Therapeutics Inc. recently announced FDA approval of its ANDA for a generic Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release suspension. CRTX 067 was developed through…
ImmunoGen Initiates Trial for Ovarian Cancer & Other Solid Tumors
ImmunoGen, Inc. recently announced the start of clinical testing with its IMGN853 product candidate.The Phase I trial initiated evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and…
Intellect Neurosciences in Dispute With Licensee Over Significant Milestone Payment
Intellect Neurosciences, Inc. recently announced an update to previously disclosed patent news. On May 8, 2012, the USPTO granted to Intellect a patent covering the…
Prokarium Acquires Key Oral Vaccine Technology
Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc. The technology includes Emergent's live Salmonella-based typhoid vaccine Typhella and its…
Sophion & Creacell Announced Successful Demonstration
Sophion and CreaCell recently announced the two companies successfully demonstrated the performances of HEK-hKir2.1 cells on QPatch HT. Inward rectifier potassium channels of the Kir2…
7/18/2012
Prokarium Acquires Key Oral Vaccine Technology Prokarium Ltd recently announced it completed a key technology acquisition from Emergent BioSolutions Inc. The technology includes Emergent's live…
EMD Millipore Expands Chemical & Reagents Portfolio
EMD Millipore, the Life Science division of Merck KGaA of Germany, recently announced a significant expansion of their chemicals and reagents product line with the introduction…
7/11/2012
RoundTable Healthcare Acquires DPT Laboratories RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, recently announced that its portfolio company,…
BASF Sells Marine Biopolymers Business
BASF SE and the Norwegian company Seagarden ASA recently announced they have signed a contract to transfer the Chitosan marine biopolymers business. Chitosan marine biopolymers…
Encap Announces Significant Capital Expenditure Program
Encap Drug Delivery recently announced a $2-million capital expenditure program to support its growing CMO activities. Following the earlier expansion in 2008 when the company…
GlobeImmune Files for $69-Million IPO
GlobeImmune, Inc. recently announced it has publicly filed a registration statement with the US SEC relating to a proposed initial public offering of shares of…
Quotient Clinical & Capsugel Announce Collaboration
Quotient Clinical and Capsugel recently announced a collaboration to enable the rapid development and clinical assessment of lipid-based formulations. Together, the companies will use their…
